Pharmacist authorship on clinical practice guidelines

Abstract

Introduction The National Academy of Medicine (NAM; formerly the Institute of Medicine) recommends multidisciplinary authorship as a standard for developing trustworthy guideline panels. The purpose of this study is to describe pharmacist authorship on clinical practice guideline (CPG) expert panels. Methods Guidelines published between January 1, 2010 and December 31, 2016 and were available in the Agency for Healthcare Research and Quality National Guideline Clearinghouse database were eligible for study inclusion. Only guidelines with pharmacotherapeutic recommendations were included. The primary end point was the proportion of pharmacist authorship on national CPGs. Pharmacist authorship by specialty area and characteristics of pharmacist authors were described. Results Of the 143 guidelines included, 58 (40.6%) had at least one pharmacist author. Guidelines developed by the Veterans Affairs/Department of Defense (VA/DoD; n = 7) and the Clinical Pharmacogenetics Implementation Consortium (CPIC; n = 13) always included at least one pharmacist. Excluding VA/DoD and CPIC guidelines, the proportion of pharmacist authorship was 30.9% (38/123). A pharmacist served as the first, senior, and/or corresponding author on 19% (27/143) of CPGs. There were 1919 total authors with an average of 13.4 (+7.4) authors per guideline. Pharmacists represented 6.8% (130/1919) of all authors, and 83 were unique pharmacist authors. Critical care, emergency medicine, and adult internal medicine guidelines had the largest proportion of pharmacist authorship, while oncology and pediatric guidelines had the smallest. Pharmacy organizations sponsored or endorsed 5.2% (3/58) of CPGs with a pharmacist author. Conclusion The majority of CPGs in this cohort did not include a pharmacist in the authorship and when included, was often limited to a single pharmacist. It is imperative for pharmacy organizations to collaborate with sponsoring medical organizations and position clinical pharmacists to serve as expert members on CPGs consistent with NAM recommendations.

Multidisciplinary Authorship Among Infectious Diseases Society of America Clinical Practice Guidelines: Examining the Contributions of Infectious Diseases Pharmacists

“…When excluding Clinical Pharmacogenomic Implementation Consortium and Veterans Affairs/Department of Defense guidelines, which have universal pharmacist participation, only 20% of national guidelines across a spectrum of disciplines include a pharmacist author [ 8 ]. Notably, high-impact guidelines such as the International Antiviral Society-USA Panel guidelines on treatment and prevention of HIV in adults and the updated Surviving Sepsis guidelines do not have pharmacist members on the expert panel despite numerous pharmacotherapeutic recommendations and recognized contributions of pharmacists in these specialty areas [ 8 , 9 ]. Not surprisingly, the antimicrobial use category within the IDSA had the highest rate of pharmacist authorship, albeit with small numbers.…”

Providing pharmacy services during the coronavirus pandemic in Saudi Arabia (Review)

“…As explicit previously, pharmacists play an elementary role in the development and implementation of institutional and national guidelines, protocols, and clinical pathways (Thompkins et al, 2019). The previous proof showed that 50% of the printed clinical follow guidelines between Jan 1, 2010, and Dec 31, 2016, had a minimum of one healthcare provider as a member of its writing panel (Thompkins et al, 2019). Pharmacists' interventions and involvement are related to higher rates of adherence to these clinical follow tips (Horning et al, 2007).…”

“…Pharmacists ought to take a proactive role in the development, implementation, and adherence to institutional and national tips concerning the emerging happening appreciate COVID-19. As explicit previously, pharmacists play an elementary role in the development and implementation of institutional and national guidelines, protocols, and clinical pathways (Thompkins et al, 2019). The previous proof showed that 50% of the printed clinical follow guidelines between Jan 1, 2010, and Dec 31, 2016, had a minimum of one healthcare provider as a member of its writing panel (Thompkins et al, 2019).…”

Is Three Company or a Crowd? Comparing and Contrasting U.S. and European Clostridioidesdifficile Clinical Practice Guidelines

“…Unsurprisingly, only one author of the ACG CPG has an infectious diseases background and only one author of the IDSA/SHEA CPG has a gastroenterology background. The authors of each CPG are represented by both physicians and pharmacists, which provides a value-added expert level review [ 15 , 16 ].…”